ST8Sia Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ST8Sia monoclonal antibodies for investigating ST8Sia protein expression and function. ST8Sia monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ST8Sia proteins participate in the biosynthesis of gangliosides, which influence cell signaling, neuronal development, and immune response modulation. ST8Sia expression patterns have been linked to various physiological processes and may contribute to cancer development and neurodegenerative conditions. Research focused on ST8Sia can reveal potential therapeutic targets and enhance understanding of disease mechanisms. Investigating ST8Sia localization and expression levels helps scientists uncover new aspects of cellular regulation and signaling pathways. Advanced research techniques combined with high-quality ST8Sia monoclonal antibodies enable detailed analysis of protein-protein interactions and cellular distribution patterns. ST8Sia monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic strategies.